Tenogenic Potential of Equine Fetal Mesenchymal Stem Cells Under The In Vitro Effect of Bone Morphogenetic Protein-12 (BMP-12).

This research investigates how bone morphogenetic protein-12 (BMP-12) influences the development of tenogenic lineage, which are the cells that make up tendons, in equine fetal bone marrow-derived stem cells (BM-MSCs).

Objective and Methodology

• The main objective of the study was to understand the potential for tenogenic differentiation in equine fetal BM-MSCs when exposed to BMP-12. Previous research established that adult BM-MSCs can develop into tenogenic cells under the influence of BMP-12, and this study intended to evaluate the same possibility for fetal BM-MSCs.
• Equine fetal BM-MSCs were exposed to different concentrations of BMP-12 (25, 50, and 100 ng/mL) over a 21-day culture period.

Markers and Identification

• To measure the effects of BMP-12, the researchers examined the mRNA levels of several tenogenic markers: decorin (DCN), tenomodulin (TNMD), scleraxis (SCX), and collagen 1α1 (COL1α1). They also evaluated protein expression of Col1α1.
• The research also confirmed that the equine fetal BM-MSCs adhered to plastic and expressed CD73, a common characteristic of MSCs. They did not express CD34, which is typical for these cells.

Findings and Implications

• Over the 21-day study period, increased levels of DCN, TNMD, SCX, and COL1α1 were observed when the equine fetal BM-MSCs were exposed to BMP-12. This indicates an activation of the genes that control tenogenic differentiation.
• This study provides new insight into the tenogenic differentiation potential of equine fetal BM-MSCs, suggesting that these cells retain the potential to develop into tendon-related cells when influenced by BMP-12. This contributes to the understanding of stem cell development, and further research in this area may ultimately lead to therapeutic applications for tendon injuries.